Market Research Logo

Cedar Pollen Allergy - Pipeline Review, H2 2018

Cedar Pollen Allergy - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cedar Pollen Allergy - Pipeline Review, H2 2018, provides an overview of the Cedar Poll


Introduction
Global Markets Direct Report Coverage
Cedar Pollen Allergy - Overview
Cedar Pollen Allergy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Cedar Pollen Allergy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Cedar Pollen Allergy - Companies Involved in Therapeutics Development
Astellas Pharma Inc
F. Hoffmann-La Roche Ltd
REGiMMUNE Corp
Stallergenes Greer plc
Cedar Pollen Allergy - Drug Profiles
ASP-4070 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biologic for Cedar Pollen Allergy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
omalizumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RGI-1001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
STG-120 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cedar Pollen Allergy - Dormant Projects
Cedar Pollen Allergy - Discontinued Products
Cedar Pollen Allergy - Product Development Milestones
Featured News & Press Releases
Mar 09, 2015: Immunomic Therapeutics to Present at BIO-Europe Annual Conference
Feb 20, 2015: Immunomic Therapeutics to Present Data on Its Proprietary LAMP Vaccine Platform at 2015 American Academy of Allergy, Asthma and Immunology Meeting
Apr 24, 2013: Immunomic Therapeutics Announces Interim Data Analysis Of Phase I Study To Treat Japanese Red Cedar Allergy
Nov 08, 2012: Immunomic Therapeutics Doses First Patient In Phase I Clinical Trial Of JRC-LAMP-Vax Vaccine To Treat Japanese Red Cedar Allergy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Cedar Pollen Allergy, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Cedar Pollen Allergy - Pipeline by Astellas Pharma Inc, H2 2018
Cedar Pollen Allergy - Pipeline by F. Hoffmann-La Roche Ltd, H2 2018
Cedar Pollen Allergy - Pipeline by REGiMMUNE Corp, H2 2018
Cedar Pollen Allergy - Pipeline by Stallergenes Greer plc, H2 2018
Cedar Pollen Allergy - Dormant Projects, H2 2018
Cedar Pollen Allergy - Discontinued Products, H2 2018
List of Figures
Number of Products under Development for Cedar Pollen Allergy, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report